Want to see JP:8129 full AI Analyst Report?
8129 Stock Chart & Stats
¥5098.00
-¥20.00(-0.47%)
At close: 4:00 PM EST
¥5098.00
-¥20.00(-0.47%)
Day’s Range― - ―
52-Week Range¥3,729.00 - ¥5,726.00
Previous CloseN/A
Volume198.00K
Average Volume (3M)153.50K
Market Cap
¥265.56B
Enterprise Value¥173.18B
Total Cash (Recent Filing)¥94.36B
Total Debt (Recent Filing)¥9.89B
Price to Earnings (P/E)15.1
Beta0.22
Next Earnings
Aug 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.06%
Share Statistics
EPS (TTM)270.02
Shares Outstanding73,025,940
10 Day Avg. Volume107,250
30 Day Avg. Volume153,503
Financial Highlights & Ratios
PEG Ratio-1.31
Price to Book (P/B)1.12
Price to Sales (P/S)0.20
P/FCF Ratio23.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)206.31
Revenue Forecast (FY)¥1.58T
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetSubstantially reduced leverage and growing equity provide durable financial flexibility. Low debt lowers refinancing and interest risk, supports investment in logistics or small M&A, and cushions earnings variability—strengthening resilience across 2–6 month to multi-year planning horizons.
Steady Revenue GrowthConsistent top-line expansion reflects persistent demand for pharmaceutical distribution services and recurring order flows from medical institutions and pharmacies. Stable revenue underpins predictable operational planning, scale economics, and long-term supplier/customer relationships.
Distribution Scale And Logistics AdvantageA broad delivery network and inventory capabilities create structural advantages versus smaller rivals: lower per-unit logistics costs, faster fill-rates, and stronger service stickiness with hospitals and pharmacies. These assets support durable competitive positioning and cross-sell into adjacent services.
Bears Say
Thin And Constrained MarginsVery low gross and net margins limit the company's ability to absorb cost shocks, invest in service upgrades or digitalization, and expand profitably. Margin compression also makes earnings highly sensitive to procurement pricing and regulatory or payer changes over the medium term.
Uneven Cash GenerationVolatile operating and free cash flow driven by working-capital swings reduces predictability for reinvestment, dividends, or debt paydown. This variability increases reliance on internal liquidity buffers and complicates medium-term capital allocation decisions.
Earnings Pressure And EPS DeclineMaterial EPS decline signals persistent profit headwinds beyond one-off items. Falling per-share earnings limit retained-earnings accumulation, constrain returns to shareholders, and may reduce room to fund strategic initiatives without eroding balance-sheet strength over the medium term.
Toho Holdings Co., Ltd. News
8129 FAQ
What was Toho Holdings Co., Ltd.’s price range in the past 12 months?
Toho Holdings Co., Ltd. lowest stock price was ¥3729.00 and its highest was ¥5726.00 in the past 12 months.
What is Toho Holdings Co., Ltd.’s market cap?
Toho Holdings Co., Ltd.’s market cap is ¥265.56B.
When is Toho Holdings Co., Ltd.’s upcoming earnings report date?
Toho Holdings Co., Ltd.’s upcoming earnings report date is Aug 05, 2026 which is in 16 days.
How were Toho Holdings Co., Ltd.’s earnings last quarter?
Toho Holdings Co., Ltd. released its earnings results on May 13, 2026. The company reported ¥44.13 earnings per share for the quarter, missing the consensus estimate of ¥45.108 by -¥0.978.
Is Toho Holdings Co., Ltd. overvalued?
According to Wall Street analysts Toho Holdings Co., Ltd.’s price is currently Overvalued.
Does Toho Holdings Co., Ltd. pay dividends?
Toho Holdings Co., Ltd. pays a Semiannually dividend of ¥90 which represents an annual dividend yield of 4.06%. See more information on Toho Holdings Co., Ltd. dividends here
What is Toho Holdings Co., Ltd.’s EPS estimate?
Toho Holdings Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Toho Holdings Co., Ltd. have?
Toho Holdings Co., Ltd. has 73,025,940 shares outstanding.
What happened to Toho Holdings Co., Ltd.’s price movement after its last earnings report?
Toho Holdings Co., Ltd. reported an EPS of ¥44.13 in its last earnings report, missing expectations of ¥45.108. Following the earnings report the stock price went down -5.152%.
Which hedge fund is a major shareholder of Toho Holdings Co., Ltd.?
Currently, no hedge funds are holding shares in JP:8129
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Toho Holdings Co., Ltd.
Toho Holdings Co., Ltd. serves as a leading wholesaler of pharmaceutical and healthcare products throughout Japan. Its extensive product range includes prescription and over-the-counter medications, reagents, medical devices and supplies, and health foods, in addition to offerings for preventive, clinical, community, and home-based medical and nursing care. Beyond distribution, the company provides comprehensive support services like developing and selling customer-focused software, assisting with the establishment of new medical facilities and pharmacies, delivering management consulting, offering medical assistance, and facilitating personnel recruitment. Toho Holdings also operates dispensing pharmacies, manufactures and distributes generic drugs, acts as a site management organization (SMO) to support clinical trials for various healthcare institutions, and supplies specialized software to the medical sector. Among its technological solutions are customer support systems such as ENIF for pharmaceutical ordering, ENI-Pharmacy for streamlining dispensing and prescribing processes, LXMATE HeLios for medical appointments, KAITOS for online medical consultations and medication guidance, ENIFwin for inventory control in large hospitals, the ENIFvoice series for voice-activated electronic medication history recording, and ENIF Nurse for home-visit nurse operational support, along with diverse logistics systems. The company, founded in 1948, is headquartered in Tokyo, Japan.
Technical Analysis
Sumitomo Dainippon Pharma Co
―
Eisai Co
―
Shionogi & Co
―
Takeda Pharmaceutical Co
―
Nippon Shinyaku Co., Ltd.
―